Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
February 6, 2022
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
Cancers
|
April 19, 2019
Frequent Occurrence of <i>NRAS</i> and <i>BRAF</i> Mutations in Human Acral Naevi
Philipp Jansen, Ioana Cosgarea, Rajmohan Murali, et al.
Pigment Cell & Melanoma Research
|
August 1, 2022
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
Anne Zaremba, Friedegund Meier, Christian Schlein, et al.
Frontiers in Genetics
|
May 27, 2021
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors
Philipp Jansen, Hansgeorg Müller, Georg C Lodde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2019
Clinical and genetic analysis of melanomas arising in acral sites
Anne Zaremba, Rajmohan Murali, Philipp Jansen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2025
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
Philipp Jansen, Wolfgang Galetzka, Carl M Thielmann, et al.
Oncoimmunology
|
September 18, 2018
Evolution of melanoma cross-resistance to CD8
Natalia Pieper, Anne Zaremba, Sonia Leonardelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance
Simone Stupia, Christina Heeke, Alicia Brüggemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2021
Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities
Eleftheria Chorti, Sied Kebir, Misbah S Ahmed, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
February 6, 2022
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
Cancers
|
April 19, 2019
Frequent Occurrence of <i>NRAS</i> and <i>BRAF</i> Mutations in Human Acral Naevi
Philipp Jansen, Ioana Cosgarea, Rajmohan Murali, et al.
Pigment Cell & Melanoma Research
|
August 1, 2022
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
Anne Zaremba, Friedegund Meier, Christian Schlein, et al.
Frontiers in Genetics
|
May 27, 2021
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors
Philipp Jansen, Hansgeorg Müller, Georg C Lodde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2019
Clinical and genetic analysis of melanomas arising in acral sites
Anne Zaremba, Rajmohan Murali, Philipp Jansen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2025
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
Philipp Jansen, Wolfgang Galetzka, Carl M Thielmann, et al.
Oncoimmunology
|
September 18, 2018
Evolution of melanoma cross-resistance to CD8
Natalia Pieper, Anne Zaremba, Sonia Leonardelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance
Simone Stupia, Christina Heeke, Alicia Brüggemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2021
Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities
Eleftheria Chorti, Sied Kebir, Misbah S Ahmed, et al.
Page
of 5